Home Tags Midphase

Tag: midphase

Allergy Therapeutics shows dose response in midphase trial, setting stage for...

A phase 2 trial of Allergy Therapeutics’ grass pollen candidate met its primary endpoint of showing a dose-response relationship. With the trial also...

As Sanofi buyout nears, Ablynx lupus drug flunks midphase trial

A phase 2 trial of Ablynx’s vobarilizumab in systemic lupus erythematosus (SLE) has missed its primary endpoint. The setback tarnishes one of the...

MorphoSys eyes MOR208 approval after midphase DLBCL data impress

MorphoSys is hoping to hustle MOR208 through an early, speedy regulatory filing after posting an upbeat look at phase 2 data. Median progression-free...

Realm scraps eye drug after midphase flop, sinking stock

Realm Therapeutics has scrapped development of PR013 after the opthalmic drops failed to improve outcomes in patients with allergic conjunctivitis. The setback wiped...

Verona jumps as midphase cystic fibrosis data dial up hopes

Shares in little Verona Pharma have jumped 20% on the back of data from a phase 2a cystic fibrosis trial. The limited look...

MOST POPULAR

HOT NEWS